The FDA's top regulator of cancer drugs interceded in a review of a Replimune skin cancer therapy, contributing to its ...

The rejection occurred amid broader turmoil at the FDA, which has been experiencing leadership changes, staff upheaval, and internal dysfunction. These organizational issues reportedly factored into ...

President Trump said Friday the U.S. is positioning two nuclear submarines in “appropriate regions” near Russia, a move he blamed on threatening rhetoric from former Russian President Dmitry Medvedev, ...